History of CAMM: In April 2009, Drs. Agus, Gross, Katz and Mallick initiated the CAMM at USC. The Center has been implemented in response to the observation that some patients experience long latent periods between diagnosis and symptomatic progression while others are afflicted with an aggressive and rapidly fatal form of the disease and the similar observation that some patients experience a complete clinical response to therapy while others will exhibit complete resistance. A technology to stratify patients according to molecular abnormalities and then apply this understanding to predict treatment responsiveness would represent an important step towards improving the care of patients. The program includes team members with expertise spanning cancer biology, biochemistry, molecular biology, bioinformatics, computer science, electrical engineering, bioorganic chemistry, statistical physics and applied mathematics.